0
     

Report Added
Report already added
Artificial Organs: Global Markets

Artificial Organs: Global Markets

Report Scope:

This report is a comprehensive study of the global artificial organs market. It describes the artificial organs market, segmented by product type and region. Based on product type, the market is segmented into artificial hearts, artificial kidneys, artificial lungs, artificial pancreases, and cochlear implants. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report examines the factors driving growth in the artificial organ market, and it reviews major players, established companies, and new entrants.

This report, however, does not cover artificial limbs, artificial eyes, artificial intestines, artificial skin, or artificial blood vessels.

Report Includes:

- 28 data tables and 14 additional tables
- An overview of the global artificial organs market
- Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
- Discussion about the benefits of using artificial organs over traditional organs in transplantation surgeries, and increase in development of new types of artificial organs as driving factors to the market
- Identification of challenges and discussion on how to overcome from those to reach its commercialization potential
- Insights into R&D investments, government growth-promoting policies, rules, and regulations
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
- Detailed company profiles of major players in the market, including Abbott, Getinge AB, LivaNova, Nipro Corp. and Sonova
Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Highlights of the Artificial Organs Market
Chapter 3 Market Overview and Definitions
Overview
Artificial Organs
Chapter 4 Market Trends
Market Drivers
Aging Population
Diabetic Cases by Countries
Chronic Kidney Disease Cases by Countries
Penetration of Artificial Organs in Emerging Markets
Market Opportunity
Market Restraints
Chapter 5 Market Breakdown by Product Type
Introduction
Artificial Heart
Artificial Kidney
Artificial Lung
Artificial Pancreas
Cochlear Implant
Chapter 6 COVID-19 Impact Analysis
Introduction
COVID-19 Impact on the Medical Devices and Pharmaceutical Industries
Decline/Delay in Elective Procedures
Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments
COVID-19 Impact on Artificial Organs Markets
Chapter 7 Market Breakdown by Region
Market Overview and Discussion
North America
U.S.
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Europe
Germany
France
U.K.
Spain
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Chapter 8 Competitive Landscape
Industry Scenario
Company Shares
Chapter 9 Emerging/Upcoming Technologies
Key/Emerging Technologies/Trends in the Market
Tissue Engineering and Regenerative Medicine
Organ-on-a-Chip
Bio-fabrication and 3D Bioprinting
Biomaterials and Biocompatible Materials
Immunomodulation and Immunotolerance Strategies
Neural Interfaces and Brain-Machine Interfaces
Gene Editing and Gene Therapy
Chapter 10 M&A and Fundings Outlook
M&A Analysis
SynCardia System's Acquisition by Versa Capital Management
Abiomed's Acquisition of Berlin Heart
LivaNova's Acquisition of TandemLife
Fresenius Medical Care's Acquisition of NxStage Medical
B. Braun's Acquisition of NxStage Medical's Bloodlines Business
LivaNova's Acquisition of TandemLife
Cantel Medical's Acquisition of hemodialysis business from Gambro
Eli Lilly's Acquisition of Protomer Technologies
Johnson & Johnson Acquisition of Abiomed Inc.
Chapter 11 Sustainability in Artificial Organs Market: An ESG Perspective
Introduction
Environmental Factors
Social Factors
Governance Factors
Artificial Organs Market: ESG Performance Analysis, by Company
Conclusion
Chapter 12 Patent Analysis
Patent Analysis by Manufacturer
Chapter 13 Pipeline Analysis
Clinical Trials Scenario
Chapter 14 Company Profiles
ABIOMED
ABBOTT
BAXTER INTERNATIONAL INC.
B. BRAUN SE
COCHLEAR LTD.
FRESENIUS MEDICAL CARE AG & CO. KGAA
F. HOFFMANN-LA ROCHE AG
GETINGE AB
INSULET CORP.
LIVANOVA PLC
MEDTRONIC
MED-EL MEDICAL ELECTRONICS
NIPRO CORP.
SONOVA
TERUMO CORP.
TANDEM DIABETES CARE, INC.
YPSOMED AG

List of Tables
Summary Table : Global Market for Artificial Organs, by Product Type, Through 2028
Table 1 : Global Population, Aged 60 and Older, 2010-2050
Table 2 : Diabetic Cases, by Country, 2000-2045
Table 3 : Chronic Kidney Disease Cases, by Country, 2017-2023
Table 4 : Global Market for Artificial Organs, by Product Type, Through 2028
Table 5 : Global Market for Artificial Hearts, by Region, Through 2028
Table 6 : Global Market for Artificial Kidneys, by Region, Through 2028
Table 7 : Global Market for Artificial Lungs, by Region, Through 2028
Table 8 : Global Market for Artificial Pancreases, by Region, Through 2028
Table 9 : Global Market for Cochlear Implants, by Region, Through 2028
Table 10 : Global Market for Artificial Organs, by Region, Through 2028
Table 11 : North American Market for Artificial Organs, by Country, Through 2028
Table 12 : Latin American Market for Artificial Organs, by Country, Through 2028
Table 13 : European Market for Artificial Organs, by Country, Through 2028
Table 14 : Asia-Pacific Market for Artificial Organs, by Country, Through 2028
Table 15 : RoW Market for Artificial Organs, Through 2028
Table 16 : Medtronic ESG Performance
Table 17 : Abbott ESG Performance
Table 18 : Cochlear Ltd. ESG Performance
Table 19 : Artificial Heart Patents, by Organization, 2019-2022
Table 20 : Artificial Kidney Patents, by Organization, 2019-2022
Table 21 : Artificial Lung Patents, by Organization, 2019-2022
Table 22 : Artificial Pancreas, by Organization, 2019-2022
Table 23 : Cochlear Implants, by Organization, 2019-2022
Table 24 : Selected Artificial Heart Devices in Clinical Trials, 2023
Table 25 : Selected Artificial Kidney Devices in Clinical Trials, 2023
Table 26 : Selected Artificial Lung Devices in Clinical Trials, 2023
Table 27 : Selected Artificial Pancreas in Clinical Trials, 2023
Table 28 : Selected Cochlear Implants in Clinical Trials, as of 2023
Table 29 : Abbott: Revenue, by Segment, 2020-2022
Table 30 : Abbott: Revenue, by Region, 2020-2022
Table 31 : Baxter International Inc.: Revenue, by Segment, 2020-2022
Table 32 : Baxter International Inc.: Revenue, by Region, 2021 and 2022
Table 33 : F. Hoffmann-La Roche Ltd.: Financials, 2020-2022
Table 34 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2020-2022
Table 35 : Getinge AB: Revenue, by Segment, 2020-2022
Table 36 : Insulet Corp.: Revenue, by Segment, 2020-2022
Table 37 : LivaNova: Revenue, by Segment, 2020-2022
Table 38 : Nipro Corp.: Revenue, by Segment, 2020-2022
Table 39 : Sonova: Revenue, by Segment, 2021 and 2022
Table 40 : Sonova: Revenue, by Region, 2021 and 2022
Table 41 : Acronyms Used in This Report

Report Title: Artificial Organs: Global Markets


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline